Skip to main content

Table 1 Study population characteristics

From: [18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial

Characteristics Value
Age Median 15.1 (7.4–19.7)
Sex  
 Male 24/34 (70.6%)
 Female 10/34 (29.4%)
Histological variant
 Osteosarcoma 17/34 (50%)
 Ewing's sarcoma 13/34 (38.2%)
 Synovial sarcoma 2/34 (5.9%)
 Liver embryonal sarcoma 2/34 (5.9%)
Site
 Extremities 22/34 (64.8%)
 Scapula 2/34 (5.9%)
 Spine 1/34 (2.9%)
 Pelvis 2/34 (5.9%)
 Chest/abdominal 3/34 (8.8%)
 Lung 1/34 (2.9%)
 Liver 3/34 (8.8%)
AJCC
 IIa 11/34 (32.4%)
 IIb 16/34 (47.1%)
 III 1/34 (2.9%)
 IV 6/34 (17.6%)
Primary therapy
 Radical surgery 29/34 (85.3%)
 Radiation therapy 5/34 (14.7%)
  1. AJCC American Joint Commission on Cancer